↓ Skip to main content

Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review

Overview of attention for article published in BMC Nephrology, December 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
51 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
Published in
BMC Nephrology, December 2014
DOI 10.1186/1471-2369-15-193
Pubmed ID
Authors

Youyuan Chen, YuMin Li, ShengLin Yang, Yan Li, Min Liang

Abstract

IgA nephropathy is the most common primary glomerular disease worldwide and also the most frequent cause of kidney failure. Mycophenolate mofetil (MMF) is a selective immunosuppressant widely used in many autoimmune diseases. However, the benefits and risks of MMF for the treatment of IgA nephropathy remain uncertain.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Slovenia 1 2%
Unknown 50 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 12%
Student > Bachelor 6 12%
Researcher 5 10%
Other 4 8%
Lecturer 4 8%
Other 13 25%
Unknown 13 25%
Readers by discipline Count As %
Medicine and Dentistry 23 45%
Biochemistry, Genetics and Molecular Biology 2 4%
Nursing and Health Professions 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Psychology 2 4%
Other 5 10%
Unknown 15 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2014.
All research outputs
#15,311,799
of 22,772,779 outputs
Outputs from BMC Nephrology
#1,442
of 2,463 outputs
Outputs of similar age
#213,123
of 359,774 outputs
Outputs of similar age from BMC Nephrology
#29
of 43 outputs
Altmetric has tracked 22,772,779 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,463 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,774 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.